We are live on ! Find out more
NCM

Nantahala Capital Management Portfolio holdings

AUM $2.72B
1-Year Est. Return 121.58%
This Fund
S&P 500
This Quarter Est. Return
+9.25%
1 Year Est. Return
+121.58%
3 Year Est. Return
+308.64%
5 Year Est. Return
+308.9%
10 Year Est. Return
+2,888.73%
AUM
$3.27B
AUM Growth
-$46.7M
Cap. Flow
-$431M
Cap. Flow %
-13.18%
Top 10 Hldgs %
56.15%
Holding
134
New
19
Increased
35
Reduced
23
Closed
20

Top Buys

Rank Stock Value
1
BMY.RT
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
+$44.1M
2
FCFS icon
FirstCash
FCFS
+$26.4M
3
SNDX icon
Syndax Pharmaceuticals
SNDX
+$20.4M
4
FTIVU
FinTech Acquisition Corp. IV Unit
FTIVU
+$20M
5
AKU
Akumin Inc
AKU
+$17.2M

Top Sells

Rank Stock Value
1
RH icon
RH
RH
+$39.3M
2
MED icon
Medifast
MED
+$37.9M
3
THC icon
Tenet Healthcare
THC
+$37.4M
4
HCA icon
HCA Healthcare
HCA
+$30.4M
5
IWM icon
iShares Russell 2000 ETF
IWM
+$22.3M

Sector Composition

Rank Sector Weight
1 Healthcare 17.92%
2 Consumer Discretionary 6.06%
3 Industrials 4.77%
4 Technology 4.5%
5 Financials 3.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PAR icon
51
PAR Technology
PAR
$735M
$14.4M 0.44%
356,637
-200,891
-36% -$7.18M
AKBA icon
52
Akebia Therapeutics
AKBA
$243M
$14.4M 0.44%
5,746,623
-354,488
-6% -$3.11M
SIC
53
DELISTED
Select Interior Concepts, Inc. Class A Common Stock
SIC
$14.2M 0.43%
2,057,208
+18,441
+0.9% +$99K
FTIVU
54
DELISTED
FinTech Acquisition Corp. IV Unit
FTIVU
$13.7M 0.42%
+1,950,000
New +$20M
SCPL
55
DELISTED
SciPlay Corporation Class A Common Stock
SCPL
$13.3M 0.41%
817,282
-547,750
-40% -$7.98M
AVTX icon
56
Avalo Therapeutics
AVTX
$1.05B
$13.2M 0.4%
2,011
+38
+2% +$286K
HAL icon
57
CALL
Halliburton
HAL
$28.2B
$13.1M 0.4%
1,086,200
– –
VMD icon
58
Viemed Healthcare
VMD
$354M
$13M 0.4%
1,498,100
– –
IWM icon
59
iShares Russell 2000 ETF
IWM
$81.9B
$12.9M 0.4%
86,413
-148,156
-63% -$22.3M
EVRI
60
DELISTED
Everi Holdings
EVRI
$12.7M 0.39%
1,541,052
+538,404
+54% +$3.74M
ZVO
61
DELISTED
Zovio Inc. Common Stock
ZVO
$11.4M 0.35%
2,853,087
+200,000
+8% +$881K
DHX icon
62
DHI Group
DHX
$162M
$10.9M 0.33%
4,839,595
– –
FTACU
63
DELISTED
FinTech Acquisition Corp. III Unit
FTACU
$10.7M 0.33%
977,022
– –
KROS icon
64
Keros Therapeutics
KROS
$210M
$10.7M 0.33%
276,827
+1,827
+0.7% +$72.5K
LINC icon
65
Lincoln Educational Services
LINC
$964M
$10.3M 0.31%
1,860,192
-576,613
-24% -$3.43M
LNW
66
DELISTED
Light & Wonder
LNW
$10M 0.31%
287,802
-309,032
-52% -$6.62M
FTOCU
67
DELISTED
FTAC Olympus Acquisition Corp. Unit
FTOCU
$10M 0.31%
+1,000,000
New +$10M
DRIO icon
68
DarioHealth
DRIO
$75.1M
$9.97M 0.31%
29,711
+19,006
+178% +$5.14M
ARYBU
69
DELISTED
ARYA Sciences Acquisition Corp II Unit
ARYBU
$9.35M 0.29%
850,000
– –
STR
70
DELISTED
Sitio Royalties
STR
$8.07M 0.25%
827,039
+328,138
+66% +$3.69M
GYRE icon
71
Gyre Therapeutics
GYRE
$710M
$7.83M 0.24%
242,900
– –
NAUT icon
72
Nautilus Biotechnolgy
NAUT
$114M
$7.57M 0.23%
+700,000
New +$7.47M
AMRS
73
DELISTED
Amyris Inc.
AMRS
$7.39M 0.23%
2,531,191
+867,020
+52% +$3.18M
GLMD icon
74
Galmed Pharmaceuticals
GLMD
$4.65M
$7.32M 0.22%
11,515
– –
RFL icon
75
Rafael Holdings
RFL
$101M
$7.03M 0.22%
459,986
-17,206
-4% -$268K
1 2
3
4 5

Similar funds

TAM
Timucuan Asset Management Jacksonville, Florida $2.72B AUM 4.95% 1-Year Est. Return
XL
XN LP New York $2.72B AUM 46.67% 1-Year Est. Return
NB
Nicolet Bankshares Green Bay, Wisconsin $2.71B AUM 17.55% 1-Year Est. Return
PA
Profund Advisors Bethesda, Maryland $2.72B AUM 47.27% 1-Year Est. Return
BCM
Bowie Capital Management Richardson, Texas $2.71B AUM 5.42% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.57% 1-Year Est. Return
HCM
Hollencrest Capital Management Newport Beach, California $2.7B AUM 23.62% 1-Year Est. Return
GC
Giverny Capital Montreal, Quebec, Canada $2.73B AUM 14.09% 1-Year Est. Return

Nantahala Capital Management's Q3 2020 Portfolio in Review

As of Q3 2020, Nantahala Capital Management held 134 positions worth $3.27B, down 1.4% from $3.32B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Nantahala Capital Management withdrew a net $431M in Q3 2020, closing 20 positions and reducing 23 holdings. Its most notable exit was RH, an estimated $39.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Industrials.

Against the trend, Nantahala Capital Management opened a new position in Bristol-Myers Squibb Company Contingent Value Rights worth $34.7M.

  • Nantahala Capital Management's largest Q3 2020 buy was Bristol-Myers Squibb Company Contingent Value Rights: 15,437,336 shares worth $34.7M.
  • Nantahala Capital Management added most to TravelCenters of America LLC in Q3 2020, an estimated $16.5M increase.
  • Nantahala Capital Management's biggest Q3 2020 reduction was Tenet Healthcare, cutting an estimated $37.4M.
  • Nantahala Capital Management fully exited RH in Q3 2020, selling an estimated $39.3M.
  • Nantahala Capital Management's ten largest holdings make up 56% of its $3.27B portfolio in Q3 2020.
  • Nantahala Capital Management opened 19 new positions and closed 20 in Q3 2020.
  • Nantahala Capital Management's portfolio value fell 1.4% quarter-over-quarter to $3.27B.

Based on Nantahala Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.